Clinical Trials Directory

Trials / Completed

CompletedNCT02620813

De Novo Lipogenesis of Sebaceous Glands in Acne

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
32 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
15 Years – 45 Years
Healthy volunteers
Accepted

Summary

There are two purposes of this study: 1. First, the investigators want to see what the differences are in de novo sebaceous lipid production of people with and without acne. 2. Secondly, the investigators want to know what happens to sebaceous gland de novo lipid production before and after treatment with topical tretinoin and oral isotretinoin.

Detailed description

The primary objective of this study is to understand how de novo lipid production of sebaceous glands are altered in acne and with acne directed therapy. Hypothesis 1: The overall de novo lipogenesis will be increased in those with acne Hypothesis 2: Treatment with topical tretinoin and systemic isotretinoin will reduce de novo lipogenesis.

Conditions

Interventions

TypeNameDescription
DRUGTretinoinSubjects will apply 0.5% tretinoin cream nightly to their face for a total of 12 weeks.
DRUGIsotretinoinSubjects will take isotretinoin as prescribed by their dermatologist.

Timeline

Start date
2015-10-01
Primary completion
2017-10-12
Completion
2017-10-12
First posted
2015-12-03
Last updated
2021-08-05

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02620813. Inclusion in this directory is not an endorsement.